tirzepatide and parkinson's disease GLP-1 does not slow progression in phase 3 study Glucagon-like peptide-1 medicines in neurological

Clinical Trial Protocols Clinical studies of Retatrutide have so far followed a once-weekly subcutaneous injection model, mirroring the approach used with other GLP-1 receptor agonists like semaglutide and tirzepatide

PlexusDx maintains no affiliate deal, partnership, or paid tie with Noom or its parent company

Tirzepatide, as the first GLP-1/GIP dual receptor agonist, demonstrated greater benefits in blood glucose control and weight reduction compared with GLP-1 single receptor agonists like semaglutide and dulaglutide, induced by the combined activation of both receptors.23,26 The latest results from the SURMOUNT-5 trial, published in May 2025, indicate that in obese individuals without diabetes, tirzepatide led to greater reductions in both weight and waist circumference compared with semaglutide

Risk Factors and Prevalence Even though we dont know the exact cause of multiple myeloma, we know some risk factors